Day: January 5, 2021

NoHo Partners PlcSTOCK EXCHANGE RELEASE 5 January 2021 at 9:00NoHo Partners has completed co-operation negotiations and organisational restructuring to adjust its operations

NoHo Partners OyjPÖRSSITIEDOTE 5.1.2021 klo 9.00NoHo Partners on saanut päätökseen yhteistoimintaneuvottelut ja organisaation uudelleenjärjestelyt toimintansa sopeuttamiseksiOsa- tai kokoaikaiset lomautukset koskevat tällä hetkellä noin 600 henkilöä. Pandemiatilanteen ja rajoitustoimenpiteiden jatkumisen vuoksi lomautusmahdollisuus on voimassa toukokuun 2021 loppuun saakka. Lomautettujen lopullinen määrä ja lomautusten kesto tarkentuvat myöhemmin markkinatilanteen muuttumisen myötä.

VANCOUVER, British Columbia, Jan. 05, 2021 (GLOBE NEWSWIRE) — VALOREM RESOURCES INC. (“VALU” or the “Company“) (CSE: VALU) (Frankfurt: 1XW1) is pleased to announce that further to its news release dated December 17, 2020, it has entered into and closed a definitive mineral property option agreement dated January 4, 2021 (the “Option Agreement”) with WBN Prospecting Group, an arm’s length party (the “Optionor”) to acquire a 100% interest in the Wing Shear property (the “Property”) located in central Newfoundland, Canada.The terms of the Option Agreement call for cash payments of $45,000 within five days of signing the agreement, $3,000,000 work commitments over 3 years, reimbursement of $13,130 in staking fees and the issuance of 4.5 million shares of the Company over a period of one year, plus a 10% finder’s...

LONDON and RALEIGH, N.C., Jan. 05, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Chief Executive Officer and President, will present a company overview at the H.C. Wainwright Virtual BioConnect Conference. The presentation will be available on-demand starting at 8:00 AM ET on Monday, January 11, 2021.A webcast of the event will be available for 30 days on the Events and Presentations link on the Investors page of the Company’s website, www.veronapharma.com.About Verona PharmaVerona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet medical needs. If successfully developed...

Press release – Paris, January 5, 2021Patricia Huyghues Despointes appointed as Chief Financial Officer of SMCPSMCP, parent company of the Sandro, Maje, Claudie Pierlot and De Fursac brands, is pleased to announce the appointment of Patricia Huyghues Despointes as Group Chief Financial Officer, after more than 15 years within the LVMH Group. In this role, Patricia Huyghues Despointes joins the SMCP Executive Committee.Daniel Lalonde, SMCP’s CEO, stated: “I am delighted to welcome Patricia to the Group’s Executive Committee as Chief Financial Officer. Over the course of her extensive career, she has led the finance functions and teams, contributing to the success of many Fashion & Luxury Brands. Her excellent knowledge of our environment and her financial expertise are major assets that will contribute to our Group’s success...

Communiqué de presse – Paris, le 5 janvier 2021Patricia Huyghues Despointes est nomméeDirecteur Administratif et Financier de SMCPLe groupe SMCP, maison mère des marques Sandro, Maje, Claudie Pierlot et De Fursac, est heureux d’annoncer la nomination de Patricia Huyghues Despointes en tant que Directeur Administratif et Financier Groupe, après plus de 15 ans passés au sein du Groupe LVMH. Elle rejoint à ce titre le Comité Exécutif de SMCP.Daniel Lalonde, Directeur général de SMCP, a déclaré : « Je suis ravi d’accueillir Patricia au sein du Comité Exécutif en tant que Directeur Administratif & Financier. Au cours de sa longue expérience, elle a conduit les équipes des départements finance, contribuant au succès de nombreuses Marques de mode et de luxe. Son excellente connaissance de l’environnement et son expertise financière...

PRESS RELEASEFirst US patient implanted in the DREAM pivotal IDE study, with the Genio® system for the treatment of Obstructive Sleep Apnea (OSA)DREAM is a pivotal, Investigational Device Exemption (IDE) study, designed to support marketing authorization in the United StatesMont-Saint-Guibert, Belgium – 5th January 2021 – Nyxoah S.A. (EBR: NYXH) (“Nyxoah” or the “Company”), a health-technology company focused on the development and commercialization of innovative solutions and services to treat Obstructive Sleep Apnea (OSA), today announces the successful implantation of the first US patient in the DREAM pivotal IDE study. The implantation took place at the Nose and Sinus Institute Boca Raton, Florida and was performed by Dr. Melyssa Hancock, Otolaryngology-Head & Neck surgeon.The DREAM (Dual-sided Hypoglossal neRvE stimulAtion for...

PRESS RELEASE

ALLSCHWIL, Switzerland, Jan. 05, 2021 (GLOBE NEWSWIRE) — Polyphor AG (SIX: POLN) announced today that Gökhan Batur, Chief Executive Officer, will take part in a panel discussion at the LifeSci Partners 10th Annual Healthcare Corporate Access Event on Thursday, January 7 from 8:00AM Eastern Standard Time.The panel is entitled “Separating the Wheat from the Chaff: Most Promising Novel Oncology Targets in Development”. Investors can pre-register for the event here.Polyphor is currently conducting the Phase III FORTRESS trial with balixafortide, a potent and selective CXCR4 antagonist, in patients with HER2 negative, locally recurrent or metastatic breast cancer. Data on the key primary endpoint of FORTRESS, progression free survival (PFS) in the overall population, is planned for Q4 2021. An analysis of the objective response rate...

SIA D Screens, 100% subsidiary of AS Ekspress Grupp, bought from SIA DIMAXI outdoor screen network with five screens in Riga. This transaction increased the D Screens screen network to 14 screens.The parties have agreed not to disclose the price or other conditions of the transaction.The group continues to actively invest in its outdoor media network both in Latvia and in Estonia.AS Ekspress Grupp also owns outdoor media company Linna Ekraanid which manages a network of 35 outdoor screens across Estonia. After the purchase, the Ekspress Grupp owns 14 digital screens in Latvia and 35 in Estonia. With a total of 49 screens, Ekspress Grupp is the second largest owner of outdoor media screens in the region and the only company that can offer its customers digital outdoor media advertising in both Estonia and Latvia.Signe KukinGroup CFOAS...